Recursion Pharmaceuticals Statistics

Total Valuation

RXRX has a market cap or net worth of $2.48 billion. The enterprise value is $2.04 billion.

Market Cap	2.48B
Enterprise Value	2.04B

Important Dates

The last earnings date was Tuesday, August 5, 2025, before market open.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	n/a

Share Statistics

RXRX has 434.66 million shares outstanding. The number of shares has increased by 57.85% in one year.

Current Share Class	427.31M
Shares Outstanding	434.66M
Shares Change (YoY)	+57.85%
Shares Change (QoQ)	+3.62%
Owned by Insiders (%)	4.14%
Owned by Institutions (%)	68.30%
Float	416.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	31.75
Forward PS	41.37
PB Ratio	2.68
P/TBV Ratio	5.99
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	31.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.58, with a Debt / Equity ratio of 0.10.

Current Ratio	3.58
Quick Ratio	3.33
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-302.76

Financial Efficiency

Return on equity (ROE) is -86.34% and return on invested capital (ROIC) is -48.30%.

Return on Equity (ROE)	-86.34%
Return on Assets (ROA)	-39.08%
Return on Invested Capital (ROIC)	-48.30%
Return on Capital Employed (ROCE)	-57.08%
Revenue Per Employee	$80,745
Profits Per Employee	-$811,415
Employee Count	800
Asset Turnover	0.06
Inventory Turnover	n/a

Taxes

In the past 12 months, RXRX has paid $17,000 in taxes.

Income Tax	17,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.47% in the last 52 weeks. The beta is 0.92, so RXRX's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-5.47%
50-Day Moving Average	5.44
200-Day Moving Average	6.19
Relative Strength Index (RSI)	51.99
Average Volume (20 Days)	27,458,219

Short Selling Information

The latest short interest is 117.54 million, so 27.04% of the outstanding shares have been sold short.

Short Interest	117.54M
Short Previous Month	115.53M
Short % of Shares Out	27.04%
Short % of Float	28.24%
Short Ratio (days to cover)	3.70

Income Statement

In the last 12 months, RXRX had revenue of $64.60 million and -$649.13 million in losses. Loss per share was -$1.80.

Revenue	64.60M
Gross Profit	-433.47M
Operating Income	-649.72M
Pretax Income	n/a
Net Income	-649.13M
EBITDA	-586.39M
EBIT	-649.72M
Loss Per Share	-$1.80

Full Income Statement

Balance Sheet

The company has $525.11 million in cash and $88.08 million in debt, giving a net cash position of $437.04 million or $1.01 per share.

Cash & Cash Equivalents	525.11M
Total Debt	88.08M
Net Cash	437.04M
Net Cash Per Share	$1.01
Equity (Book Value)	919.15M
Book Value Per Share	2.12
Working Capital	423.13M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$383.03 million and capital expenditures -$10.84 million, giving a free cash flow of -$393.87 million.

Operating Cash Flow	-383.03M
Capital Expenditures	-10.84M
Free Cash Flow	-393.87M
FCF Per Share	-$0.91

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,005.81%
Pretax Margin	-1,004.88%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RXRX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.85%
Shareholder Yield	-57.85%
Earnings Yield	-26.20%
FCF Yield	-15.90%

Dividend Details

Analyst Forecast

The average price target for RXRX is $7.00, which is 22.81% higher than the current price. The consensus rating is "Buy".

Price Target	$7.00
Price Target Difference	22.81%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RXRX has an Altman Z-Score of 0.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.32
Piotroski F-Score	1